Search Results
Aug 17, 2026, 21:16 ET Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-dsgr-hlx-atai-crnx-obtaining-fair-deals-for-their-shareholders-302853324.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 06, 2026, 22:31 ET Are UTZ, VEEE, CRNX Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-utz-veee-crnx-obtaining-fair-deals-for-their-shareholders-302845604.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 06, 2026, 16:33 ET SHAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--CRNX, PSBQ, UTZ, and VEEE
CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected
More news about: Monteverde & Associates PC
Aug 03, 2026, 19:39 ET Are ACA, CRNX, LEG Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-aca-crnx-leg-obtaining-fair-deals-for-their-shareholders-302841702.htmlSOURCE
More news about: Halper Sadeh LLP
Aug 03, 2026, 15:21 ET $HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger--ACA, CRNX, LEG, and LPSN
CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected
More news about: Monteverde & Associates PC
Jul 28, 2026, 10:50 ET Are UTZ, CRNX, SOLS Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-utz-crnx-sols-obtaining-fair-deals-for-their-shareholders-302836470.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 23, 2026, 13:41 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected
More news about: Monteverde & Associates PC
Jul 21, 2026, 14:51 ET Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-crnx-veee-nxtc-tcbk-obtaining-fair-deals-for-their-shareholders-302831187.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 16, 2026, 14:23 ET $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESI, CRNX, SOLS, and PATK
CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected
More news about: Monteverde & Associates PC
Jul 14, 2026, 16:09 ET Are CRNX, VEEE, ESI Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-crnx-veee-esi-obtaining-fair-deals-for-their-shareholders-302825517.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 09, 2026, 19:11 ET Are ESI, CRNX, SOLS Obtaining Fair Deals for their Shareholders?
multimedia:https://www.prnewswire.com/news-releases/are-esi-crnx-sols-obtaining-fair-deals-for-their-shareholders-302822300.htmlSOURCE
More news about: Halper Sadeh LLP
Jul 09, 2026, 13:22 ET $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX)
CRNX) related to its sale to Vertex Pharmaceuticals Incorporated. Under the terms of the proposed transaction, Crinetics shareholders are expected
More news about: Monteverde & Associates PC
Jul 06, 2026, 19:41 ET Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
MILWAUKEE, July 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Crinetics (Nasdaq: CRNX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Vertex.
More news about: Ademi LLP
Dec 19, 2025, 07:55 ET Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
(NASDAQ: GTBP), ADC Therapeutics SA (NYSE: ADCT), Sutro Biopharma, Inc. (NASDAQ: STRO), Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), and TScan Therapeutics, Inc. (NADSAQ: TCRX).
More news about: Equity Insider